Barclays Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $26
Barclays Keeps Their Buy Rating on Organon (OGN)
Evercore Initiates Organon & Co(OGN.US) With Buy Rating
Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma
Organon Analyst Ratings
J.P. Morgan Downgrades Organon & Co(OGN.US) to Sell Rating, Raises Target Price to $20
Barclays Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $26
Barclays Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $26
Organon Analyst Ratings
Organon Analyst Ratings
Goldman Sachs Maintains Neutral on Organon, Raises Price Target to $20
Organon Analyst Ratings
Piper Sandler Maintains Overweight on Organon, Raises Price Target to $24
Piper Sandler Reaffirms Their Buy Rating on Organon (OGN)
Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating
Organon Analyst Ratings
Piper Sandler Remains a Buy on Organon (OGN)
Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $22
Organon Analyst Ratings
Analyst Ratings for Organon